The carboxypeptidase U system in atherosclerosis : insights in carboxypeptidase U mediated pleiotropic effects of statins

Bron
Antwerpen, Universiteit Antwerpen, Faculteit Farmaceutische, Biomedische en Diergeneeskundige Wetenschappen, Departement Farmaceutische Wetenschappen, 2022,xv, 289 p.

Activation of the carboxypeptidase U (CPU, TAFIa, CPB2) system in patients with SARS-CoV-2 infection could contribute to COVID-19 hypofibrinolytic state and disease severity prognosis

Bron
2022,
Auteur(s)

Carboxypeptidase U (TAFIa) is rapidly activated and deactivated following thrombolysis and thrombectomy in stroke patients

Bron
2021,11 p.
Auteur(s)

Pleiotropic effects of Atorvastatin result in a downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a mouse model of advanced atherosclerosis

Bron
2021,9 p.
Auteur(s)